Stem Cell Technology: Novel Treatment Shows Promise For Nonhealing Digital Ulcers
Saturday, 05 September 2009 11:11
Ilya Petrou, M.D.
Published: Sep 1, 2009
Source: http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Stem-cell-technology-Novel-treatment-shows-promise/ArticleStandard/Article/detail/622608?ref=25

Introduction:
Stem cells have been used for the treatment of difficult-to-heal cutaneous wounds, such as diabetic and venous leg ulcers, as well as large defects following skin cancer surgery. Recent research has shown that this therapeutic approach not only can help close other cutaneous wounds, but it can do so quickly, bringing much-needed relief to these patients.

"After achieving very positive results in leg ulcers by using stem cell technology, we applied this approach with the addition of bioengineered skin to the digital ulcers seen in systemic sclerosis (scleroderma) patients and managed to close the wounds within two weeks.

"For cutaneous wounds that are difficult to heal, the use of stem cells combined with bioengineered skin appears to be a promising therapeutic option, as wounds' closure speed is dramatic," says Vincent Falanga, M.D., F.A.C.P., professor of dermatology and biochemistry at Boston University, Boston, and chairman of the department of dermatology and skin surgery at Roger Williams Medical Center in Providence, R.I. He is also the principal investigator of a recently renewed National Institutes of Health Center of Biomedical Research Excellence at the medical center, totally focused on tissue repair and stem cells.

Continue Reading here:
 
More articles :

» A Scleroderma Fact Sheet

Below, is a very useful fact sheet on Scleroderma. Making for much easier reading and reference, this fact sheet highlights what Scleroderma is, how is it diagnosed, who gets it, complications which may arise, and how it can be treated. Feel free to...

» Unite Against Scleroderma 2014

For the fourth year running, we will be hosting our annual “Unite Against Scleroderma” Awareness Walk. Scheduled to start from 2:30pm, the Walk would be held on Saturday 3rd May, 2014 and cover one full lap around the Queen’s Park Savannah,...

» No Exercise Benefit with Bosentan in Systemic Sclerosis

Treatment with the endothelin receptor antagonist bosentan () failed to improve exercise capacity in patients with systemic sclerosis, a randomized trial found. After one year of treatment, there was a nonsignificant mean change in the six-minute...

» Scleroderma in Children: Emerging Management Issues

Saumya PandaDepartment of Dermatology, KPC Medical College, Kolkata, IndiaDate of Web Publication: 21-Jul-2010Abstract         Scleroderma is a set of rare connective tissue diseases of unknown etiology. It is...

» Patients With Scleroderma May Not Exhibit Increased Corneal Thickness

in patients with systemic sclerosis may not differ significantly from those of healthy patients, contrary to prior hypothesis, a study found."Because [] is characterized by increased deposition of and other connective tissue components in the skin...

» Unite Against Scleroderma 2012

{gallery}unite3{/gallery}